Outcomes in Patients with Liver Dysfunction Post SARS-CoV-2 Infection: What Should We Measure?

By sjmartinez • October 18, 2023

John N, Ibrahim B, Ebaid M, Saab S. Outcomes in Patients with Liver Dysfunction Post SARS-CoV-2 Infection: What Should We Measure? Hepat Med. 2023 Oct 12;15:185-193. doi: 10.2147/HMER.S371507. PMID: 37850074; PMCID: PMC10578169.

Tags: cholangiopathy, Cirrhosis, covid-19, Digestive Diseases, Fellow, liver injury, Publications, Thrombosis

Gregory F. Sonnenberg, PhD Appointed Director of the UCLA Center for Research in Inflammatory Bowel Disease

It is with great enthusiasm that we announce that Gregory F. Sonnenberg, PhD, has accepted the appointment as director of the UCLA Center for Research[...]

Radiology considerations for the PREMIUM study: a multicenter randomized controlled trial of abbreviated MRI versus ultrasound for liver cancer screening in cirrhosis

Dunn DP, Dani G, Sharma A, Ioannou GN, Taddei TH, Chang ST, Onyiuke IY, Planeta BM, Huang GD, Weiss NS, Morgan TR, Dominitz JA, Abou-Alfa[...]

Effect of Age and Age-Defined Menopausal Status on Linaclotide Efficacy and Safety in Adults With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation: Post Hoc Analyses of Phase 2b/3 Studies

Chang L, Staller K, Houghton LA, Yerneni N, Higgins S, Chen W, Wu J, Ford AC, Feuerstadt P, Brenner DM. Effect of Age and Age-Defined[...]